Mechanistic and Translational Insights of CARv3-TEAM-E in Glioblastoma
Cancer Network,
Introduction Glioblastoma (GBM) remains among the most lethal adult solid tumors, with a median overall survival of…
Mechanistic and Translational Insights of CARv3-TEAM-E in Glioblastoma
UBM Medica,
The INCIPIENT trial establishes CARv3-TEAM-E as a mechanistically sophisticated and biologically active platform for recurrent…
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
Cancer Network,
Background: Why Delivery Has Become the Next Barrier Chimeric antigen receptor (CAR) T-cell therapy has fundamentally reshaped…
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
UBM Medica,
In vivo CAR T-cell engineering represents a fundamental rethinking of how cellular therapies are produced and delivered.